Citius Pharmaceuticals, Inc. — Investor Relations & Filings
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company that develops and commercializes critical care products. The company's diversified pipeline focuses on anti-infectives in adjunct cancer care, stem cell therapies, and prescription products. Its portfolio includes LYMPHIR™, an FDA-approved therapy for adult patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Key product candidates in development include Mino-Lok®, an antibiotic lock solution intended to treat patients with catheter-related bloodstream infections, and Halo-Lido, a topical formulation for the treatment of hemorrhoids. Additionally, the company is advancing a stem cell therapy platform for conditions such as acute respiratory distress syndrome (ARDS).
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| CURRENT REPORT | 2026-06-01 | English | |
| REGISTRATION STATEMENT | 2026-05-22 | English | |
| CURRENT REPORT | 2026-05-15 | English | |
| QUARTERLY REPORT | 2026-05-15 | English | |
| 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English | |
| 424B5 - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47923554 | CURRENT REPORT | 2026-06-01 | English | ||
| 46860857 | REGISTRATION STATEMENT | 2026-05-22 | English | ||
| 46362590 | CURRENT REPORT | 2026-05-15 | English | ||
| 46363360 | QUARTERLY REPORT | 2026-05-15 | English | ||
| 36278647 | 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English | ||
| 36137720 | 424B5 - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English | ||
| 33641001 | 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-06 | English | ||
| 33122239 | 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-03-31 | English | ||
| 32892870 | 8-K - CITIUS PHARMACEUTICALS, INC. (0001506251) (Filer) | 2026-03-04 | English | ||
| 32892869 | ARS - CITIUS PHARMACEUTICALS, INC. (0001506251) (Filer) | 2026-02-24 | English | ||
| 32892871 | DEF 14A - CITIUS PHARMACEUTICALS, INC. (0001506251) (Filer) | 2026-02-24 | English | ||
| 30211696 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30211698 | 10-Q Filing | 2026-02-13 | English | ||
| 30211695 | 8-K Filing | 2026-02-13 | English | ||
| 30211697 | 10-K/A Filing | 2026-01-28 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIOVIE INC.
Develops drug therapies for neurological disorders and adva…
|
BIVI | US | Manufacturing |
|
BioXcel Therapeutics, Inc.
Biopharmaceutical company using AI to develop drugs for neu…
|
BTAI | US | Manufacturing |
|
Bioxel Pharma Inc.
Develops, manufactures, and markets taxane APIs, essential …
|
— | CA | Manufacturing |
|
BIOXYNE LIMITED
Life sciences company focused on probiotics, medicinal cann…
|
BXN | AU | Manufacturing |
|
B&K CORPORATION LIMITED
Innovative biopharma developing PDGF therapeutic drugs for …
|
2396 | HK | Manufacturing |
|
Black Diamond Therapeutics, Inc.
Develops precision oncology therapies targeting families of…
|
BDTX | US | Manufacturing |
|
BLAU FARMACÊUTICA S.A.
Multinational producer of high-complexity medications for h…
|
— | BR | Manufacturing |
|
Bliss GVS Pharma Limited
Global leader in suppository and pessary production for eme…
|
BLISSGVS | IN | Manufacturing |
|
Blis Technologies Limited
Develops and commercializes patented probiotic strains for …
|
BLT | NZ | Manufacturing |
|
Bloomage Biotechnology Corporation Limited
Global leader in hyaluronic acid and bioactive substance re…
|
688363 | CN | Manufacturing |
Citius Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34965/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34965 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34965 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34965 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34965}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Citius Pharmaceuticals, Inc. (id: 34965)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.